Advisor - GPU Platform Engineering at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Expertise in Linux system administration, HPC environments, and Nvidia DGX server management
Experience with Spectrum X networking and parallel file systems
Strong scripting skills and familiarity with containerization and automation tools
6+ years of demonstrated experience in AI/ML and HPC workloads and infrastructure
Hands-on experience in using or operating High Performance Computing (HPC) grade infrastructure
In-depth knowledge of accelerated computing (e.g., GPU), storage (e.g., Weka), scheduling & orchestration (e.g., Slurm, Kubernetes, LSF), high-speed networking (e.g., Ultra-Ethernet, RoCE), and containers technologies (Docker)
Passion for continual learning and keeping abreast of new technologies and effective approaches in the AI/ML infrastructure field
Expertise in running and optimizing large-scale distributed training workloads using PyTorch (DDP, FSDP), NeMo, or JAX
Deep understanding of AI/ML workflows, encompassing data processing, model training, and inference pipelines
Some proficiency in at least one scripting language such as Bash, Python, or equivalent
Basic Qualifications: Bachelor’s degree in computer science, Information Technology, or related technical field
10+ years’ experience as a Linux OS/Platform Engineer

Responsibilities

Driving the engineering and operations of advanced Linux platforms supporting AI and HPC workloads
Managing Nvidia DGX systems using Mission Control, Base Command, and Run:AI
Optimizing Spectrum X networking and WEKA storage for AI/ML applications
Boosting productivity for Advanced Intelligence and Data science teams through implementing advancements across AI/HPC infrastructure tooling and operational excellence
Working in the Infrastructure Hosting Platform area leading the strategy, engineering, and development of Advanced Linux computing capabilities for AI/ML
Advising with senior Linux platform engineer directing the global Linux strategy for on-premises private cloud and public IaaS Linux services
Accelerating initiatives in AI/ML acceleration, Infrastructure AI OPS automation, HPC management, and infrastructure as code to enable critical business projects
Building secure, resilient, and reliable hybrid cloud services using proactive, predictive, and automated capabilities

Skills

Linux

NVIDIA DGX

Spectrum-X

WEKA Storage

Run:AI

Base Command

Mission Control

HPC

AI/ML

Infrastructure Engineering

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free